Erratum for Grossman et al., Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic

Antzeko izenburuak

• Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
  nork: Grossman, Trudy H., et al.
  Argitaratua: (2012)
• Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
  nork: Sutcliffe, J. A., et al.
  Argitaratua: (2013)
• Eravacycline (TP-434) Is Active In Vitro against Biofilms Formed by Uropathogenic Escherichia coli
  nork: Grossman, Trudy H., et al.
  Argitaratua: (2015)
• Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
  nork: Grossman, Trudy H., et al.
  Argitaratua: (2017)
• Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
  nork: Grossman, Trudy H., et al.
  Argitaratua: (2015)